These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25296234)

  • 21. Immunosuppression in the pediatric transplant recipient.
    Blondet NM; Healey PJ; Hsu E
    Semin Pediatr Surg; 2017 Aug; 26(4):193-198. PubMed ID: 28964473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive regimens and their effects on renal allograft outcome.
    Katznelson S; Cecka JM
    Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
    Lim WH; Chang SH; Chadban SJ; Campbell SB; Dent H; Russ GR; McDonald SP
    Transplantation; 2009 Nov; 88(10):1208-13. PubMed ID: 19935375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal transplantation at the University of Minnesota during the 1980s.
    Fryd DS; Migliori R; Simmons RL; Chavers B; Dunn D; Payne W; Canafax DM; Sutherland DE; So SS; Mauer SM
    Clin Transpl; 1987; ():167-81. PubMed ID: 3154396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why does kidney allograft fail? A long-term single-center experience.
    Alarrayed S; El-Agroudy A; Al-Arrayed A; Ghareeb S; Farid E; Garadah T; Abdulla S
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):818-24. PubMed ID: 21743242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Present state of immunosuppressive therapy in liver transplant recipients.
    Wiesner RH; Fung JJ
    Liver Transpl; 2011 Nov; 17 Suppl 3():S1-9. PubMed ID: 21850697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney transplantation in hepatitis C-positive recipients: does type of induction influence outcomes?
    Sureshkumar KK; Thai NL; Marcus RJ
    Transplant Proc; 2012 Jun; 44(5):1262-4. PubMed ID: 22663997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What immunosuppression should be used for old-to-old recipients?
    Le Meur Y
    Transplant Rev (Orlando); 2015 Oct; 29(4):231-6. PubMed ID: 26409505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
    Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
    Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients.
    Sung J; Barry JM; Jenkins R; Rozansky D; Iragorri S; Conlin M; Al-Uzri A
    Pediatr Transplant; 2013 Dec; 17(8):718-25. PubMed ID: 24164824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000.
    Gruessner AC; Sutherland DE
    Clin Transpl; 2000; ():45-72. PubMed ID: 11512358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
    Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunosuppressive protocols in kidney transplantation: with or without induction?].
    Nehme Chelala D; Mourani C; Moukarzel M; Azar H
    J Med Liban; 2015; 63(3):150-3. PubMed ID: 26591195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic Risk Assessment and Approach to Immunosuppression Regimen in Kidney Transplantation.
    Choi J; Chandraker A
    Clin Lab Med; 2019 Dec; 39(4):643-656. PubMed ID: 31668275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Now or never? The case for cell-based immunosuppression in kidney transplantation.
    Hutchinson JA; Geissler EK
    Kidney Int; 2015 Jun; 87(6):1116-24. PubMed ID: 25738251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.